EBV-positive Primary Pulmonary Lymphoepithelioma-like Carcinoma Response to PD-L1 Blockade

Anand Narayanan, Friedrich D Knollmann, Julie Ann S. Walby, Steffany Lim, David R Gandara, Jonathan Riess

Research output: Contribution to journalArticle

3 Scopus citations
Original languageEnglish (US)
JournalClinical Lung Cancer
DOIs
StateAccepted/In press - Jan 1 2019

Keywords

  • Atezolizumab
  • EBV-positive malignancy
  • Immunotherapy
  • PD-L1 antibody
  • Pulmonary lymphoepithelioma-like carcinoma

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this